|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02616 CSTONE PHARMA-B
Nominal 
2.270 +0.040 (+1.794%) Non-current Assets
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 138,379 | -10.240% | 154,166 | 39,367 | 14,185 | 14,473 |
| Land & other Lease Assets | 68,187 | 138.158% | 28,631 | 27,175 | 4,469 | 0 |
| Intangible Assets | 159,699 | 126.398% | 70,539 | 6,509 | 1,305 | 897 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 25,245 | -58.253% | 60,472 | 117,398 | 43,843 | 11,800 |
| 391,510 | 24.761% | 313,808 | 190,449 | 63,802 | 27,170 | |
Current Assets
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Inventories | 22,188 | -63.841% | 61,363 | 0 | 0 | 0 | |
| Trade Receivables | 77,133 | -34.410% | 117,598 | 0 | 0 | 0 | |
| Cash & Bank Balances | 558,684 | -24.779% | 742,724 | 3,024,548 | 1,126,436 | 701,336 | |
| Other Current Assets | 588,912 | -43.153% | 1,035,960 | 547,755 | 1,760,407 | 903,612 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 1,246,917 | -36.305% | 1,957,645 | 3,572,303 | 2,886,843 | 1,604,948 | ||
Current Liabilities
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |||
| Trade Payables | 290,414 | -29.901% | 414,293 | 28,030 | 37,304 | 4,559 | ||
| S-T Debt & Leases | 44,918 | 2.207% | 43,948 | 11,314 | 4,344 | 0 | ||
| Other Current Liabilities | 611,150 | 28.743% | 474,707 | 687,705 | 416,316 | 1,104,663 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 946,482 | 1.451% | 932,948 | 727,049 | 457,964 | 1,109,222 | |||
| Net Current Assets | 300,435 | -70.681% | 1,024,697 | 2,845,254 | 2,428,879 | 495,726 | ||
| Total Assets Less Current Liabilities | 691,945 | -48.305% | 1,338,505 | 3,035,703 | 2,492,681 | 522,896 | ||
Non-current Liabilities
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||||
| L-T Debt & Leases | 241,372 | 85.314% | 130,250 | 72,545 | 0 | 0 | |||
| Other Non-current Liabilities | 1,247 | 0.000% | 1,247 | 8,698 | 11,099 | 7,565 | |||
| 242,619 | 84.505% | 131,497 | 81,243 | 11,099 | 7,565 | ||||
Capital and Reserves
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |||||
| Share Capital | 802 | 0.754% | 796 | 787 | 687 | 123 | ||||
| Reserves | 448,524 | -62.815% | 1,206,212 | 2,953,673 | 2,480,895 | 515,208 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 449,326 | -62.774% | 1,207,008 | 2,954,460 | 2,481,582 | 515,331 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 449,326 | -62.774% | 1,207,008 | 2,954,460 | 2,481,582 | 515,331 | |||||
Commitments and Contingent Liabilities
| 2022/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Commitments | 0 | -- | 34,690 | 82,269 | 4,020 | 9,048 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 04/02/2025 13:43 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 15,699,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 0.364 |